Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Sodium Nitrite
Therapeutic Area : Endocrinology
Study Phase : Phase II
Sponsor : Kettering Health Network
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 09, 2015
Lead Product(s) : Sodium Nitrite
Therapeutic Area : Endocrinology
Highest Development Status : Phase II
Sponsor : Kettering Health Network
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Sodium Nitrite
Therapeutic Area : Undisclosed
Study Phase : Phase I/ Phase II
Recipient : University of Colorado, Boulder
Deal Size : Inapplicable
Deal Type : Inapplicable
Sodium Nitrite to Treat Arterial Aging
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 30, 2013
Lead Product(s) : Sodium Nitrite
Therapeutic Area : Undisclosed
Highest Development Status : Phase I/ Phase II
Recipient : University of Colorado, Boulder
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Sodium Nitrite
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 25, 2011
Lead Product(s) : Sodium Nitrite
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable